Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - VIG, Valneva, Wolford (01/12/2022)

04.12.2022

Vienna Insurance Group: The international rating agency Standard & Poor's (S&P) once again confirmed Vienna Insurance Group's (VIG) rating of "A+" with a stable outlook in its press release on 1 December 2022. As in the previous year, the rating agency considers the financial risk profile of Vienna Insurance Group to be very strong. Once again S&P continues to view VIG's excellent capital adequacy to be a relative ratings strength.
VIG: weekly performance: -3.06%

Valneva: Valneva and Pfizer reported antibody persistence data six months after the completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule with their Lyme disease vaccine candidate, VLA15 in both children and adults. This is the first time antibody persistence data are reported in pediatric populations for this vaccine candidate. The results further validate the use of the three-dose vaccination schedule which is also included in the Phase 3 protocols for all participants. No vaccine-related serious adverse events (SAEs) and no safety concerns were observed in this six-month observational follow up.
Valneva: weekly performance: 3.28%

Wolford: The Extraordinary General Meeting of bodywear group Wolford AG voted in favor of a capital reduction and a subsequent capital increase. The capital increase is to be implemented in the first quarter of 2023. Upon implementation of the capital increase, the Company will receive up to 20,157,450.00 euros. The shareholders are granted the statutory subscription right. "We are pleased that the Annual General Meeting has approved the capital increase. This will strengthen our equity base and allow us to systematically pursue our strategy to further develop the Wolford brand," explains Executive Board member Silvia Azzali.
Wolford: weekly performance: -5.00%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (01/12/2022)


Partners









latest 21st Austria

21st Austria weekly - VIG, Valneva, Wolford (01/12/2022)


04.12.2022, 1894 Zeichen



Vienna Insurance Group: The international rating agency Standard & Poor's (S&P) once again confirmed Vienna Insurance Group's (VIG) rating of "A+" with a stable outlook in its press release on 1 December 2022. As in the previous year, the rating agency considers the financial risk profile of Vienna Insurance Group to be very strong. Once again S&P continues to view VIG's excellent capital adequacy to be a relative ratings strength.
VIG: weekly performance: -3.06%

Valneva: Valneva and Pfizer reported antibody persistence data six months after the completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule with their Lyme disease vaccine candidate, VLA15 in both children and adults. This is the first time antibody persistence data are reported in pediatric populations for this vaccine candidate. The results further validate the use of the three-dose vaccination schedule which is also included in the Phase 3 protocols for all participants. No vaccine-related serious adverse events (SAEs) and no safety concerns were observed in this six-month observational follow up.
Valneva: weekly performance: 3.28%

Wolford: The Extraordinary General Meeting of bodywear group Wolford AG voted in favor of a capital reduction and a subsequent capital increase. The capital increase is to be implemented in the first quarter of 2023. Upon implementation of the capital increase, the Company will receive up to 20,157,450.00 euros. The shareholders are granted the statutory subscription right. "We are pleased that the Annual General Meeting has approved the capital increase. This will strengthen our equity base and allow us to systematically pursue our strategy to further develop the Wolford brand," explains Executive Board member Silvia Azzali.
Wolford: weekly performance: -5.00%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (01/12/2022)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Austrian Stocks in English: ATX TR in week 5 unchanged at high levels, but RHI Magnesita changes the Index Picture




 

Bildnachweis

Aktien auf dem Radar:AT&S, RBI, Polytec Group, Warimpex, RHI Magnesita, Kapsch TrafficCom, EVN, Österreichische Post, Telekom Austria, voestalpine, Cleen Energy, Mayr-Melnhof, Palfinger, Bawag, Marinomed Biotech, OMV, Kostad, Porr, Stadlauer Malzfabrik AG, AMS, Agrana, Flughafen Wien, Oberbank AG Stamm, Frequentis, S Immo, Amag, FACC, Immofinanz, Strabag, Verbund, Zumtobel.


Random Partner

Frequentis
Frequentis mit Firmensitz in Wien ist ein internationaler Anbieter von Kommunikations- und Informationssystemen für Kontrollzentralen mit sicherheitskritischen Aufgaben. Solche „Control Center Solutions" entwickelt und vertreibt Frequentis in den Segmenten Air Traffic Management (zivile und militärische Flugsicherung, Luftverteidigung) und Public Safety & Transport (Polizei, Feuerwehr, Rettungsdienste, Schifffahrt, Bahn).

>> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten